- Home
- WAL vs CORT Comparison
WAL vs CORT Comparison
Compare WAL & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WAL | CORT |
|---|---|---|
| Founded | 1994 | 1998 |
| Country | United States | United States |
| Employees | 3524 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 3.7B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | WAL | CORT |
|---|---|---|
| Price | $66.64 | $33.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 6 |
| Target Price | $98.40 | ★ $105.20 |
| AVG Volume (30 Days) | ★ 1.7M | 1.7M |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | ★ 2.46% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | ★ $761,407,000.00 |
| Revenue This Year | $20.16 | $29.97 |
| Revenue Next Year | $8.63 | $30.25 |
| P/E Ratio | ★ $10.88 | $40.91 |
| Revenue Growth | N/A | ★ 12.79 |
| 52 Week Low | $57.05 | $28.66 |
| 52 Week High | $97.23 | $117.33 |
Technical Indicators
Market Signals| Indicator | WAL | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 24.06 | 37.40 |
| Support Level | N/A | $28.66 |
| Resistance Level | $87.53 | $41.92 |
| Average True Range (ATR) | 3.17 | 1.26 |
| MACD | -1.20 | 0.29 |
| Stochastic Oscillator | 0.44 | 35.65 |
Price Performance
Historical ComparisonAbout WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.